Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why
Jim Cramer, the host of Mad Money, reflected on the uncertainty surrounding the year 2025, focusing on several macroeconomic ...
Zacks.com on MSN23h
CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors
In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day.
VOE: Average Historical Return, But Good Dividend Growth
Vanguard Mid-Cap Value ETF features solid sector diversification. Learn why VOE's stock ranking and cash-flow valuation ...
SG Americas Securities LLC Has $831,000 Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)
SG Americas Securities LLC decreased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 17.9% during the 4th quarter, according to the company in its most recent disclosure with the ...
Geneos Wealth Management Inc. Has $219,000 Holdings in Vanguard Mega Cap ETF (NYSEARCA:MGC)
Geneos Wealth Management Inc. raised its holdings in Vanguard Mega Cap ETF (NYSEARCA:MGC – Free Report) by 6.6% in the fourth quarter, according to the company in its most recent Form 13F filing with ...
Bloomberg L.P.23h
CRSP US Large Cap Index
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...